Skip to search formSkip to main contentSkip to account menu

TE33

Known as: I 3.3 
Provider: Technion University, Haifa, Israel. No information from provider. This cell line meets the criteria for the use of human embryonic stem… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
The structure of a complex of the anti‐cholera toxin antibody TE33 Fab (fragment antibody) with the D‐peptide vpGsqhyds was… 
2006
2006
The onset of autoimmune diseases is proposed to involve binding promiscuity of antibodies (Abs) and T‐cells, an often reported… 
2003
2003
The purpose of this study was to examine the ventilatory responses during a six-minute walk test (6MWT), an incremental shuttle… 
1998
1998
We have transformed two peptide epitopes into D-peptide analogs: VPGSQHIDS derived from cholera toxin recognized by the antibody… 
Highly Cited
1993
Highly Cited
1993
Cholera toxin peptide 3 (CTP3) is a 15-residue peptide corresponding in sequence to an immunogenic loop on the surface of the B… 
Highly Cited
1992
Highly Cited
1992
Intramolecular interactions in bound cholera toxin peptide (CTP3) in three antibody complexes were studied by two-dimensional… 
Highly Cited
1991
Highly Cited
1991
mAb raised against synthetic peptides derived from cholera toxin, myohemerythrin, and sickle hemoglobin were analyzed by both… 
1990
1990
The interactions between the aromatic residues of the monoclonal antibody TE34, and its peptide antigen CTP3, have been studied… 
1989
1989
The interactions between the aromatic amino acids of two monoclonal antibodies (TE32 and TE33) with specific amino acid residues… 
1988
1988
The contact interactions between a synthetic peptide and three different anti-peptide monoclonal antibodies have been studied by…